Baxter International Inc (BAX) stock
Close on Nov 11, 2026Market cap $13.63BP/E –Yield 1.97%
Baxter International Inc grew revenue 5.3% to $11.61B over the twelve months to Sep 30, 2026. Free cash flow was $332.00M, down 42.1% from a year earlier. At the latest close the market valued the company at $13.63B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $13.63B
- P/E ratio
- –
- Price to sales
- 1.17
- Price to book
- 2.10
- Dividend yield
- 1.97%
- Free cash flow yield
- –
Fundamentals
- Revenue
- $11.61B
- Net income
- -$723.00M
- EPS, diluted
- -$1.43
- Free cash flow
- $332.00M
- Book value per share
- $12.50
- Diluted shares
- 520M
Trading
- Next earnings
- Feb 11, 2027 (estimated, before the open)
- Previous close
- $26.42
- Open
- $26.11
- Day's range
- $25.98 – $26.50
- Volume
- 3,826,031
- Average volume (20 days)
- 7,498,092
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 0.79
- 52-week range
- $15.73 – $30.00
- RSI (14 days)
- 58.6
- Volatility (1 year)
- 42.2%
- Relative volume
- 0.57×
- WACC
- 9.0%
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BAX | S&P 500 | Difference | BAX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +8.2% | -2.4% | +10.6 pts | ||
| 3 months | -4.6% | -1.2% | −3.4 pts | ||
| Year to date | +38.0% | +12.3% | +25.7 pts | ||
| 1 year | +44.6% | +12.4% | +32.2 pts | ||
| 3 years | -15.1% | +78.8% | −94.0 pts | -5.3% | +21.4% |
| 5 years | -63.3% | +75.2% | −138.5 pts | -18.2% | +11.9% |
| 10 years | -34.4% | +311.1% | −345.5 pts | -4.1% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Baxter International filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- News
- News
- News
- Results
About Baxter International
Surgical & Medical Instruments & Apparatus
Baxter International Inc. provides essential healthcare products and therapies across three primary operating segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. Its portfolio includes sterile intravenous solutions, infusion systems, parenteral nutrition therapies, surgical sealants and equipment, smart beds, patient monitoring systems, respiratory health devices, specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. These products serve diverse healthcare providers, including hospitals, nursing homes, rehabilitation centers, ambulatory surgical facilities, doctor offices, dialysis centers, and home-care patients.
Company profile, executives and historyBaxter International stock: common questions
What is Baxter International's stock price?
BAX closed at $26.34 on Nov 11, 2026, down 0.30% on the day. Over the past 52 weeks it traded between $15.73 and $30.00.
What is Baxter International's market cap?
Baxter International was worth $13.63B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is BAX's P/E ratio?
Baxter International lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.43), so it has no meaningful P/E ratio.
How much revenue does Baxter International make?
Baxter International reported revenue of $11.61B for the twelve months to Sep 30, 2026, up 5.3% from a year earlier.
Does Baxter International pay a dividend?
Yes. Baxter International paid $0.52 per share over the last twelve months, a yield of 1.97% at the latest price.
When does Baxter International report earnings next?
Baxter International is expected to report Q4 FY2026 results on Feb 11, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has BAX stock performed over the past year?
Including dividends, BAX returned +44.6% over the past year, against +12.4% for the S&P 500.
How many BAX shares are sold short?
24M shares were sold short at the latest FINRA report, 4.60% of the float, or 3.0 days of average trading volume.
Who are Baxter International's competitors?
Companies most similar to Baxter International by business, industry and size include SOLV, BDX, BSX, RMD, TFX.
See a number that looks wrong?